Exelixis (EXEL) Construction in Progress (2010 - 2017)
Exelixis (EXEL) recorded quarterly Construction in Progress of $14.5 million in Q2 2017, up 3079.82% quarter-over-quarter from $456000.0 in Q4 2015.
Exelixis (EXEL) Construction in Progress (2010 - 2017) Analysis & Trends
Exelixis' Construction in Progress history runs 7 years deep, the most recent figure standing at $14.5 million for Q2 2017.
- In Q2 2017, Construction in Progress changed N/A year-over-year to $14.5 million; the TTM figure through Jun 2017 stood at $14.5 million (changed N/A YoY), while the FY2015 annual figure was $456000.0, up 280.0% from the prior year.
- Construction in Progress was $14.5 million for Q2 2017 at Exelixis, up from $456000.0 in the prior quarter.
- In the past five years, Construction in Progress ranged from a high of $14.5 million in Q2 2017 to a low of $68000.0 in Q4 2013.
- Historically, Construction in Progress has averaged $3.8 million across 4 years, with a median of $288000.0 in 2014.
- The sharpest annual moves came in 2013 and 2015: Construction in Progress plunged 95.17% in 2013, then surged 280.0% in 2015.
- A 4-year view of Construction in Progress shows it stood at $68000.0 in 2013, then jumped by 76.47% to $120000.0 in 2014, then soared by 280.0% to $456000.0 in 2015, then surged by 3079.82% to $14.5 million in 2017.
- The last three Construction in Progress figures came in at $14.5 million (Q2 2017), $456000.0 (Q4 2015), and $120000.0 (Q4 2014), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Construction in Progress (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | - |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | Exelixis | 13.37 Bn | 12.59 Bn | 590.86 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2017 | 14.50 Mn |
| Dec 31, 2015 | 456,000.00 |
| Dec 31, 2014 | 120,000.00 |
| Dec 31, 2013 | 68,000.00 |
| Dec 31, 2012 | 1.41 Mn |
| Dec 31, 2011 | 155,000.00 |
| Dec 31, 2010 | 373,000.00 |